These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2708545)

  • 1. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
    Neusy AJ; Lowenstein J
    J Clin Pharmacol; 1989 Jan; 29(1):18-24. PubMed ID: 2708545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
    Wilkinson PR; Raftery EB
    Br J Clin Pharmacol; 1977 Jun; 4(3):289-94. PubMed ID: 332218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
    Strauss FG; Franklin SS; Lewin AJ; Maxwell MH
    JAMA; 1977 Oct; 238(16):1734-6. PubMed ID: 578267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
    Franklin SS; Tonkon MJ; Kirschenbaum MA; Dobak JD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S244-7. PubMed ID: 2455188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of clonidine and propranolol as monotherapy in borderline hypertension.
    Cottier C; Julius S
    Chest; 1983 Feb; 83(2 Suppl):422-5. PubMed ID: 6337032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonidine withdrawal. Mechanism and frequency of rebound hypertension.
    Geyskes GG; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1979 Jan; 7(1):55-62. PubMed ID: 760743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrupt discontinuation of clonidine therapy.
    Ram CV; Engelman K
    JAMA; 1979 Nov; 242(19):2104-5. PubMed ID: 490793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.
    Pérez-Stable EJ; Coates TJ; Baron RB; Biró BS; Hauck WW; McHenry KS; Gardiner PS; Feigal D
    J Gen Intern Med; 1995 Aug; 10(8):419-28. PubMed ID: 7472698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine and guanfacine in hypertension.
    Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
    Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.
    Hansson L; Hunyor SN; Julius S; Hoobler SW
    Am Heart J; 1973 May; 85(5):605-10. PubMed ID: 4697628
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of central noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal.
    Augustine SJ; Buckley JP; Tachikawa S; Lokhandwala MF
    J Cardiovasc Pharmacol; 1982; 4(3):449-55. PubMed ID: 6177942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
    Hunyor SN; Hansson L; Harrison TS; Hoobler SW
    Br Med J; 1973 Apr; 2(5860):209-11. PubMed ID: 4700009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy: clonidine, a new antihypertensive drug.
    Pettinger WA
    N Engl J Med; 1975 Dec; 293(23):1179-80. PubMed ID: 1102978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.